Wang Huijun, Jiang Jiayao, Zhou Guochao, Zhang Yelei
Department of Neurosurgery, Xishan People's Hospital of Wuxi City, Wuxi Branch of Zhongda Hospital Southeast University, Wuxi, People's Republic of China.
Department of Orthopedics, The 904th Hospital of the Joint Logistics Support Force of the PLA, Wuxi, Jiangsu Province, People's Republic of China.
Neuropsychiatr Dis Treat. 2025 May 16;21:1057-1065. doi: 10.2147/NDT.S515306. eCollection 2025.
Heart rate variability (HRV), as a safe and noninvasive marker of autonomic activity, is becoming a prescreening tool for the prediction of cardiovascular complications such as myocardial infarction and heart failure after cerebral stroke. With good reproducibility and quantitative assessment of autonomic nervous system function, the association of some HRV parameters with neurological functional prognosis and stroke recurrence has been widely reported. However, current studies on the relationship between HRV and the clinical outcomes of stroke remain controversial. Previous studies on HRV have mainly focused on stroke prognosis or its role as a clinical biomarker, whereas other roles have rarely been explored. In this article, we review recent advances in the role of HRV in cerebral stroke according to current progress. Specifically, we summarized the role of HRV in the outcomes, complications, treatments, and mechanisms of stroke, based on the latest research. Further, in-depth implications of HRV in stroke are discussed.
心率变异性(HRV)作为自主神经活动的一种安全且无创的标志物,正成为预测心血管并发症(如脑卒中后心肌梗死和心力衰竭)的一种预筛查工具。由于其具有良好的可重复性以及对自主神经系统功能的定量评估,一些HRV参数与神经功能预后及卒中复发之间的关联已被广泛报道。然而,目前关于HRV与卒中临床结局之间关系的研究仍存在争议。以往关于HRV的研究主要集中在卒中预后或其作为临床生物标志物的作用,而其他作用则很少被探讨。在本文中,我们根据当前进展综述了HRV在脑卒中介入的最新进展。具体而言,我们基于最新研究总结了HRV在卒中结局、并发症、治疗及机制方面的作用。此外,还讨论了HRV在卒中方面的深入意义。